On Invalid Date, Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q3 2023 earnings per share (EPS) of -$0.89, up 85.24% year over year. Total Kiora Pharmaceuticals earnings for the quarter were -$6.29 million. In the same quarter last year, Kiora Pharmaceuticals's earnings per share (EPS) was -$6.03.
As of Q4 2023, Kiora Pharmaceuticals's earnings has grown year over year. Kiora Pharmaceuticals's earnings in the past year totalled -$13.27 million.
What was KPRX's revenue last quarter?
On Invalid Date, Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Kiora Pharmaceuticals's revenue was $0.00.
What was KPRX's revenue growth in the past year?
As of Q4 2023, Kiora Pharmaceuticals's revenue has grown null year over year. Kiora Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.